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Abstract 
 
The objective of this project was to evaluate the biological activity of peptides derived 
from the EC-4 domain of E-cadherin in inhibiting E-cadherin-mediated cell-cell 
adhesion. The activity of these peptides was determined by inhibition of Caco-2 single 
cells that bind to a Caco-2 monolayer and inhibition of junction resealing of MDCK II cell 
monolayers. The results showed that peptide 6 (LVVQAADLQG) derived from the EC-2 
domain and peptide 8 derived from the EC-4 domain (YTALIIATDN) of E-cadherin were 
more effective in inhibiting single cell adhesion than peptides from other domains (EC-1, 
EC-3) of E-cadherin. Peptide 8 had better activity than peptide 6. From overlapping 
hexapeptides derived from peptide 8, it was found that peptide 12 with ALIIAT sequence 
had the best activity, suggesting that it was the activity sequence of peptide 8. Alanine-
scanning and mutation experiments found that peptide 22 (TEIIAT) had the best activity 
compared to other hexapeptides derived from peptide 8 in inhibiting cell adhesion of 
Caco-2 cells and junction resealing of MDCK-II cell monolayers.  
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Introduction  
Cell-cell adhesion processes in the intercellular junctions of biological barriers (i.e., 
intestinal mucosa barrier and blood-brain barrier (BBB)) are indispensable in the 
integrity of the intercellular junctions of these barriers [1].  The intercellular junctions are 
segregated into tight junctions, adherens junctions, and desmosomes and by protein-
protein interactions at the extracellular and cytoplasmic domains [1, 2]. The tight 
junctions are mediated by membrane proteins such as claudin and occluding and 
junctional adhesion molecules (JAM) proteins [1-3]. The tight junction proteins interact 
with cytoplasmic domain proteins such as zonula occludin-1 and -2 (ZO-1, ZO-2) [3]. 
The adherens junctions are constructed with calcium-binding E-cadherin and non-
calcium-binding nectin proteins. At the cytoplasmic domain, E-cadherins bind to alpha-, 
beta-, and gamma-catenins, which connect them to cytoskeletal proteins[4]. The 
desmosomes are mediated by desmosomal cadherins called desmogleins and 
desmocollins, and they bind to cytoplasmic plaque proteins [2]. 
The highly conserved His-Ala-Val (HAV) sequence in the extracellular-1 (EC-1) 
domain was reported to be important for homophilic binding between cadherins [5]. Our 
group designed HAV and Ala-Asp-Pro (ADT) peptides derived from the respective 
groove and bulge regions of the EC-1 domain of E-cadherin [6]. These peptides 
modulated the intercellular junctions of MDCK II cell monolayers as measured by the 
lowering of the trans-epithelial electrical resistance (TEER) values of the monolayers [7, 
8]. Cadherin peptides improved the penetration of 14C-mannitol through the MDCK II cell 
monolayers as well as that of 14C-mannitol and 3H-daunomycin across the BBB in in-situ 
rat brain perfusion [7-9]. Recently, HAV and ADT peptides have been shown to improve 
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in vivo brain delivery of a gadopentetic acid, a contrast agent for magnetic resonance 
(MRI), into the brains of Balb/c mice [6, 10].  
Although HAV and ADT peptides were active in modulating cell-cell adhesion in the 
intercellular junctions, there is no information as to whether peptides from the groove 
and bulge regions of other domains (i.e., EC-2, -3, and -4) are active in inhibiting E-
cadherin-mediated cell-cell adhesion. Therefore, the study was focused on evaluating 
the activities of peptides 1–8 derived from the bulge and groove regions of the EC-1 
(Table 1), EC-2, EC-3, and EC-4 domains of human E-cadherin to inhibit E-cadherin-
mediated Caco-2 single cells and Caco-2 cell monolayers. This study was also done to 
evaluate the inhibition activity of hexapeptides (peptides 10–24) derived from peptide 8 
in inhibiting E-cadherin-mediated cell-cell adhesion.    
 
Materials and Methods 
Cells and Reagents 
Fmoc amino acids, activating agents, and solvents for peptide synthesis were 
purchased from Bachem, Inc. (Torrance, CA). Other chemicals and solvents were 
purchased from Sigma Chemicals (St. Louis, MO). Caco-2 and Madin-Darby Canine 
Kidney (MDCK II) cells were purchased from ATCC (Manassas, VA). 10% fetal bovine 
serum (FBS) containing Dulbecco’s modified Eagle’s medium (DMEM), anti-E-cadherin 
rat monoclonal antibody (U3254), anti-rat IgG-FITC conjugate antibody (F1763), and 
anti-mouse IgG-FITC conjugate antibody (F4143) were purchased from Sigma. An anti-
E-cadherin monoclonal antibody (SHE78-7) was purchased from PanVera (Madison, 
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WI). The fluorescence marker (2’,7’-bis(2-carboxyethyl)-5(and-6)-carboxy-fluorescein 
acetoxymethyl ester or BCECF-AM) was purchased from Molecular Probes (Eugene, 
OR). Dimethyl sulfoxide (DMSO), Triton X-100 and other reagents were purchased from 
Sigma.  
 
Synthesis and Purification of Peptides 
All the peptides were synthesized using a solid-phase peptide synthesis method 
utilizing Fmoc chemistry in a Pioneer Peptide Synthesizer. After cleavage from the 
resin, the peptide was precipitated in cold ether to produce a crude product. Then, the 
crude product was purified using a semi-preparative C18 HPLC column and the 
separated compounds were collected using fraction collectors. The fractions containing 
the desired peptide were determined using analytical HPLC and a C18 column; these 
pure fractions were removed, and the solution of pure peptide was lyophilized. The 
identity of the pure peptide was determined by mass spectrometry. 
 
Inhibition of Caco-2 Single Cell Adhesion to Caco-2 Cell Monolayers by Cadherin 
Peptides 
Caco-2 cells were maintained in 10% FBS containing DMEM (FBS/DMEM) in T-75 
plastic flasks (Falcon) at 37ºC in a humidified 5% CO2 atmosphere. Culture medium 
was changed every other day. Cells were subcultured at least once a week so that the 
cells did not reach confluency. Caco-2 cells were seeded on 48-well culture dishes and, 
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after the cells monolayers were confluent, the medium was replaced with BSA/DMEM. 
Another Caco-2 cell layer in a T-75 flask was treated with Ca2+- and Mg2+-free Hank’s 
balanced saline solution (HBSS-) to obtain the Caco-2 single cells. The isolated Caco-2 
single cells were incubated with 5.0 µg/mL of BCECF-AM containing FBS/DMEM for 90 
min at 37ºC under the humidified 5% CO2 atmosphere to label the single cells with the 
fluorescence marker BCECF. After the incubation, BCECF-labeled cells were washed 
extensively with PBS- (80 mM Na2HPO4, 20 mM KH2PO4, 140 mM NaCl, 10 mM KCl, 
pH 7.4) to remove excess fluorescence marker. BCECF-Caco-2 cells were re-
suspended in BSA/DMEM at a density of 4 × 105 cells/mL. 
The BCECF-Caco-2 single cell suspension was mixed with peptide solution at 1:1 
dilution; the BCECF-Caco-2 cells were then added to Caco-2 cell monolayers on a 48-
well culture plate (5 × 104 cells/200 µL/well). Single cells and the cell monolayers were 
co-incubated for 2 h in the dark at 37ºC under the humidified 5% CO2 atmosphere. After 
the incubation, the wells were washed three times with PBS+ (0.63 mM CaCl2, 0.74 mM 
MgCl2, and 1.0 mg/mL glucose in PBS-) to wash away non-bound cells. The cell layers 
with bound BCECF-Caco-2 cells were lysed with 350 µL/well of 3.0% Triton X-100 
solution. Lysates were collected in micro-centrifuge tubes, and centrifuged at 10,000 
rpm for 10 min at room temperature. The supernatants (150 µL/well) were transferred to 
black 96-well plates in duplicate for measuring the fluorescence intensities (excitation at 
485 nm; emission at 530 nm) using a Fluorescence Microplate Reader (FL600, Bio-
Tek). 
For activity to inhibit cell-cell adhesion, peptides and antibodies were prepared at a 
2-fold concentration for their final concentrations. Antibodies as well as peptides 0, 1, 2,-
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3, 4, and 9 were first dissolved in 98.0% volume of 0.1% BSA contained DMEM 
(BSA/DMEM). Then 2.0% volume of DMSO was added. Due to their hydrophobic 
nature, peptides 5, 6, 7, and 8 were first dissolved in 2.0% volume of DMSO, followed 
by addition of 98.0% volume of BSA/DMEM. A 2.0% DMSO containing DMEM was 
used as a control vehicle. Finally, all samples contained 1.0% DMSO. 
 
Immunofluorescence Staining of E-cadherin Molecules 
Caco-2 cell monolayers were cultured on 48-well plates, washed three times with 
PBS+, and fixed overnight at 4ºC in 4.0% formaldehyde solution. After three-time 
washing for 5 min in PBS+, several of the cell monolayers were permeabilized by 
treatment with 0.5% Triton X-100 solution. The cell monolayers, washed three times 
with PBS+, were treated with blocking buffer (5% skim milk and 1% BSA in PBS+) for 
60 min at room temperature to prevent the non-specific binding of antibodies. Cell 
monolayers were washed again, as above, and incubated with 250 µL/well of 2 µg/mL 
of anti-E-cadherin monoclonal antibody (SHE78-7) containing blocking buffer at 4ºC 
overnight. The cell monolayers were then washed three times with washing buffer 
(0.05% Tween 20 in PBS+) followed by 60 min-treatment at 37ºC with FITC-conjugated 
antimouse IgG antibody in 1:50 dilution in blocking buffer. The cell monolayers were 
washed five times with washing buffer, and the localization of E-cadherin molecules was 
observed under a fluorescence microscope (Nikon).  
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Inhibition of Junction Resealing of MDCK Cell Monolayers by Cadherin Peptides 
MDCK strain-2 cells were cultured using the Eagle’s medium (Cellgro, Manassas, 
VA) containing 1.42 g/L HEPES sodium, 100 units/mL penicillin, 10% fetal bovine serum 
(Atlanta Biologicals, Lawrenceville, VA, USA), and 100 µg/mL streptomycin (Atlanta 
Biologicals). The cells (100,000 cells/well) were seeded on polyethylene membrane 
Transwells (0.4 µm; diameter 1.12 cm2) from Costar (Cambridge, MA, USA) until the 
cell monolayers were confluent with TEER values above 300 Ohm.cm2 around day 7. 
Hank’s balanced salt solution (HBSS) containing 1% glucose, 10 mM HEPES, and 2.0 
mM CaCl2 at pH 7.4 was used to wash the monolayers, and the TEER values of intact 
MDCK monolayers were measured in HBSS after incubation for 1.5 h for equilibration 
using EVOM2 (World Precision Instruments, Sarasota, FL, USA). To open the 
intercellular junctions, the cell monolayers were incubated in calcium-deficient HBSS for 
1 h and then the media was switched to calcium-sufficient media in the absence or 
presence of different concentrations of peptides. The effects of peptide concentrations 
in inhibiting the resealing of the intercellular junctions were monitored by the TEER 
values of the cell monolayers.  Each experiment was conducted at least in triplicate.  
 
Statistical Analysis 
The results were presented as the mean ± SD of 4–6 determinations. Statistical 
analyses were determined by Dunnett’s multiple comparison test when the data were 
regarded as the parametric data in Bartlet’s test, or Dunnett’s multiple rank test when 
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the data were considered as the non-parametric data, with p values below 0.05 
regarded as significant using a statistical analysis software, SAS.  
 
Results 
The Presence of E-cadherin on the Junctions of Permeabilized and Normal Caco-
2 Cell Monolayers 
The presence of E-cadherin on modified and normal Caco-2 cell monolayers was 
detected using mouse anti-E-cadherin antibody (mAb) and FITC-labeled secondary IgG 
antibody. To detect E-cadherin at the adherens junctions of Caco-2 cell monolayers, the 
monolayers were disrupted using Triton X-100 to allow the penetration of the mAbs 
through the tight junctions. The results indicated that anti-E-cadherin mAb decorates the 
intercellular junctions of Caco-2 cell monolayer as shown by fluorescence microscopy 
(Figures 1A); the cells were still anchored on the polycarbonate membrane on the well 
after Triton X-100 treatment as revealed by light microscopy (Figure 1B). The normal 
cell monolayers were treated with the anti-E-cadherin mAb; some E-cadherins were 
located on the surface of the monolayer (Figure 1C), and the cell monolayer was 
visualized with light microscopy (Figure 1D). As a negative control, the cell monolayer 
was incubated with FITC-labeled anti-mouse IgG, and no decoration of fluorescence on 
the surface due to non-specific binding of the IgG mAb was seen (Figures 1 E&F). 
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Figure 1: Localization of E-cadherin protein in the adherens junctions of modified and 
normal Caco-2 cell monolayers.  (A) Fluorescence and (B) light contrast microscopy of 
normal Caco-2 cell monolayers treated with Triton X-100 C followed by treatment with 
anti-E-cadherin and FITC-anti-mouse IgG Ab. (C) Fluorescence and (D) light contrast 
microscopy of normal Caco-2 cell monolayers treated with anti-E-cadherin and FITC-
anti-mouse IgG Ab. (E) Fluorescence and (F) light contrast microscopy of normal Caco-
2 cell monolayers treated with control mouse IgG and FITC-anti-mouse IgG Ab.  
 
  
D) F) B) 
C) E) A) 
        0.5% Triton X-100                                        PBS+                                  PBS+ 
1st Ab: anti-E-cad. mouse Ab.               anti-E-cad. mouse Ab                             Mouse IgG 
2ndAb: FITC-anti-mouse IgG Ab            FITC-anti-mouse IgG Ab                FITC-anti-mouse IgG Ab 
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Figure 2: Time course for the adhesion of BCECF-labeled Caco-2 single cells to 
modified Caco-2 cell monolayers. BCECF-labeled Caco-2 single cells were incubated 
onto modified Caco-2 cell monolayers in the absence (closed circles) or presence (open 
circles) of anti-E-cadherin mAb (50x).  The culture medium contained 1.0% DMSO.  
Data are shown as the mean ± SD of 6 determinations. The anti-E-cadherin mAb 
blocked the adhesion of single cells to cell monolayers, suggesting that the cell 
adhesion was partially mediated by E-cadherins.  **: p<0.01 significantly different from 
the control group, which did not contain anti-E-Cadherin mAb, in the same incubation 
period. 
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Table 2. Inhibitory activities of E-Cadherin-derived peptides in Caco-2 single cell 
adhesion to Caco-2 cell monolayer. NS: No significant change from control. 
 
 
 
Table 1.  Amino acid sequence of E-cadherin-related peptides. 
 
Peptide No. Origin Region   Amino Acid Sequences 
0 EC-1 domain Scramble   HSASVA 
1 EC-1 domain Bulge   Q42GADTPPVGV51 
2 EC-2 domain Bulge   Q154DPELPDKNM163 
3 EC-3 domain Bulge   N264DDGGQFVVT273 
4 EC-4 domain Bulge   T368YRIWRDTA*1N377 
5 EC-1 domain Groove   L77FSHAVSSNG86 
6 EC-2 domain Groove   L190VVQAADLQG199 
7 EC-3 domain Groove   Y297ILHVAVTNV306 
8 EC-4 domain Groove   Y407TALIIATDN416 
9 EC-1 domain Groove   D68RERIATYTLFSHAVSSNGNAVED91 
]*1: The original sequence is R376 
 
Conc. Inh. Stat. vs cont.
mM      Mean ± SD % p. value
Control - - 6 1,915.0 ± 93.37 -   -   
Peptide-0 N/R 1.0 6 1,798.8 ± 139.42 6.1 N S
Peptide-1 EC-1 1.0 6 1,940.3 ± 130.60 -1.3 N S
Peptide-2 EC-2 1.0 6 2,033.3 ± 63.12 -6.2 N S
Peptide-3 EC-3 1.0 6 1,978.5 ± 75.54 -3.3 N S
Peptide-4 EC-4 1.0 6 1,970.0 ± 100.11 -2.9 N S
Peptide-5 EC-1 1.0 6 1,468.8 ± 35.51 23.3 N S
Peptide-9 EC-1 0.5 6 800.2 ± 108.34 58.2 p < 0.01
Peptide-6 EC-2 1.0 6 1,014.5 ± 124.08 47.0 p < 0.01
Peptide-7 EC-3 1.0 6 1,919.8 ± 58.40 -0.3 N S
Peptide-8 EC-4 1.0 6 1,047.7 ± 77.43 45.3 p < 0.05
E-Cad. mAb. - 50 x 6 1,005.8 ± 88.02 47.5 p < 0.01
Peptide No. Origin n
Fluorescence Intensity
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E-cadherin-mediated Caco-2 Single Cell Adhesion to Modified Caco-2 Cell 
Monolayers 
To evaluate the activity of cadherin peptides, a cell adhesion assay was performed 
using E-cadherin-mediated BCECF-Caco-2 single cells adhesion onto modified Caco-2 
cell monolayers. The amount of single cell adhesion was assumed to be proportionate 
to the fluorescence intensity in the well from the adhering single cells. As shown in 
Figure 2, the amount of adhesion of BCECF-Caco-2 single cells onto the cell monolayer 
was dependent on the incubation time of single cells as determined by the increase in 
fluorescence intensity. At 2- and 4-h time points, the single cells were incubated onto 
cell monolayers in the presence of anti-E-cadherin mAb. The fluorescence intensities 
from the single cells were significantly lower in the presence of anti-E-cadherin mAb 
than without mAb (Figure 2) at both the 2- and 4-h time points. The result suggested 
that E-cadherin was involved in the adhesion of single cells to the cell monolayers.  
Using this assay, the ability of various cadherin peptides (Table 1) to inhibit single 
cells adhesion to cell monolayers was evaluated by measuring the inhibition of 
fluorescence intensities from labeled Caco-2 single cells (Table 2). Peptides 1–4 were 
derived from the respective bulge regions of the EC-1, EC-2, EC-3, and EC-4 domains 
of E-cadherin, and peptides 5–8 were derived from the groove regions of the EC-1, EC-
2, EC-3, and EC-4 domains. Peptide 0 is a scrambled peptide derived from the HAV 
groove region (SHAVSS) of the EC-1 domain of E-cadherin. Peptide 9, which served as 
a positive control, was derived from the HAV groove region of EC1. As a positive 
control, the results showed that peptide 9 produced the strongest inhibition of cell-cell 
adhesion (58.2%) at 0.5 mM concentration (Table 2). Another positive control was anti-
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E-cadherin mAb, which inhibited cell adhesion by 47.5%.  As a negative control, peptide 
0 did not have any effect on inhibiting cell-cell adhesion at 1.0 mM concentration. At 1.0 
mM concentration, peptides 6 and 8, which were obtained from the respective groove 
regions of EC-2 and -4 domains, significantly blocked the cell-to-cell adhesion at 47% 
and 45% inhibition, respectively (Table 2). Peptide 5, which contained the HAV 
sequence, had weak inhibitory activity (23%) in this cell adhesion assay, and peptide 7, 
derived from the groove region of the EC-3 domain, did not inhibit cell-to-cell adhesion.  
In this assay, peptides 1–4 from the respective bulge regions of EC-1, -2, -3, and -4 did 
not show any inhibitory activity. 
The concentration-dependent activities of peptides 6, 8, and 9 were evaluated and 
compared to control buffer, peptide 0, and anti-E-cadherin mAb (Figures 3–5). The 
activity of peptide 9 was concentration-dependent and similar to that of anti-E-cadherin 
mAb (50x) at 500 μM (Figure 3). Peptide 6 showed a trend of concentration-dependent 
inhibition of cell adhesion, and significant inhibition of cell adhesion was observed at the 
peptide concentration of 750 μM with maximum activity at 1000 μM (Figure 4). The 
activity of peptide 8 was also concentration-dependent, and inhibition was observed as 
low as 250 μM concentration with the maximum activity around 750μM (Figure 5).  
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Figure 3: Concentration-dependent inhibitory activity of peptide 9 on Caco-2 single cell 
adhesion to Caco-2 cell monolayer. Data are shown as the mean ± SD of 6 
determinations.  *: p<0.05 and **: p<0.01 significantly different from the control group in 
Dunnett’s multiple rank test. Ctrl: Control, P-0: peptide 0, mAb: Anti-E-cadherin mAb. 
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Figure 4: Concentration-dependent inhibitory activity of peptide 6 on Caco-2 single cell 
adhesion to Caco-2 cell monolayer. Data are shown as the mean ± SD of 6 
determinations.  **: p<0.01 significantly different from the control group in Dunnett’s 
multiple rank test. Ctrl: Control Group; P-0: peptide 0; mAb: Anti-E-cadherin mAb 
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Figure 5: Concentration-dependent inhibitory activity of peptide 8 on Caco-2 single cell 
adhesion to Caco-2 cell monolayer. Data are shown as the mean ± SD of 6 
determinations.  *: p< 0.05 and **: p<0.01 significantly different from the control group in 
Dunnett’s multiple rank test. Ctrl: Control, P-0: peptide 0, mAb: Anti-E-cadherin mAb.  
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Table 3.  Sequence of hexapeptides from EC-4 domain. 
 
Peptide No. Origin Nature   Amino Acid Sequences 
8 EC-4 domain Parent   YTALIIATDN 
10 EC-4 domain Overlapping   YTALII 
11 EC-4 domain Overlapping   TALIIA 
12 EC-4 domain Overlapping   ALIIAT 
13 EC-4 domain Overlapping   LIIATD 
14 EC-4 domain Overlapping   IIATDN 
15 EC-4 domain Ala-Scan   AAIIAT 
16 EC-4 domain Ala-Scan   ALAIAT 
17 EC-4 domain Ala-Scan   ALIAAT 
18 EC-4 domain Ala-Scan     ALIIAA 
19 EC-4 domain Mutant     TLIIAT 
20 EC-4 domain Mutant     TAIIAT 
21 EC-4 domain Mutant     TFIIAT 
22 EC-4 domain Mutant     TEIIAT 
23 EC-4 domain Mutant     TNIIAT 
24 EC-4 domain Mutant     TRIIAT 
17 
 
 
 
Figure 6: Concentration-dependent inhibitory activity of peptide 8 and its derivatives on 
Caco-2 single cell adhesion to Caco-2 cell monolayer. Data are shown as mean of 4 
determinations for each concentration. 
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Reduction of Peptide 8 Decapeptide to Hexapeptides 
To evaluate the important sequence and to reduce the size of peptide 8, five 
overlapping hexapeptides were synthesized (Table 3) and their ability to inhibit cell 
adhesion were determined in a concentration-dependent manner (Figure 7). Peptide 8 
(YTALIIATDN) was the most potent in inhibiting cell adhesion, and its inhibition effect 
was concentration-dependent. The ALIIAT hexapeptide (peptide 12) had consistent 
inhibitory activity at 500, 750, and 1000 μM concentrations, and it had better activity 
than all other hexapeptides at 750 and 1000 μM.  
Next, alanine scanning was carried out on ALIIAT to determine amino acids that 
were important for the biological activity (Figure 8). Replacement of the Leu-2, Ile-4, and 
Thr-6 residues in the alanine residue enhanced the activities, suggesting that these 
residues are important for activity. One of the best peptides was ALIAAT (peptide 17), in 
which the Ile-4 residue was replaced with Ala-4. To evaluate the effect of Ala-1 on 
ALIIAT, the first residue was replaced with Thr-1 to make TLIIAT (peptide 19), and the 
presence of a hydroxyl group in Thr-1 was to enhance the solubility of the peptide. 
Mutation of Ala-1 to Thr-1 to make TLIIAT did not improve the inhibitory activity at the 
given concentration. Because the Leu-2 was important for activity, as shown from the 
alanine scanning, the Leu-2 residue in TLIIAT was mutated to Ala-2, Phe-2, Glu-2 Asn-
2, and Arg-2 to give TAIIAT, TFIIAT, TEIIAT, TNIIAT, and TEIIAT (Table 3). The results 
showed that replacing Leu-2 with hydrophobic Ala-2 (TAIIAT; peptide 20) and Phe-2 
(TFIIAT; peptide 21) improved peptide activities compared to those of the parent 
TLIIAT.  Replacing Leu-2 with acid Glu-2, neutral Asn-2, and basic Arg-2 also improved 
the peptide activity, and the best activity was seen in TEIIAT with Glu-2 residue. Thus, 
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TEIIAT was used for a further study to inhibit junction resealing of MDCK cell 
monolayers.  
 
 
 
 
Figure 7: Evaluation of the effect of alanine scanning and residue mutation of ALIIAT 
peptide using Caco-2 single cell adhesion to Caco-2 cell monolayers at 250 μM peptide 
concentration. The inhibition of cell adhesion was measured by fluorescence intensities 
from the single cells, and the results were shown as percent of cell adhesion in the 
presence of peptide compared to the negative control. The positive control is anti-E-
cadherin mAb. Data are shown as the mean ± SD of 6 determinations. **: p<0.01 
significantly different from the control group in Dunnett’s multiple rank test. Ctrl: Control, 
mAb: Anti-E-cadherin mAb.  
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Figure 8:  Concentration-dependent inhibition of junction resealing of MDCK monolayers 
by TEIIAT. Data are shown as mean ± SD of 3 determinations. **; p <0.01 and *: p<0.05 
statistically significant from the control group. 
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Figure 9: The effect of concentration on junction resealing inhibitory activity of TEIIAT 
peptide on MDCK-2 cell monolayers at time 6 h. Data are shown as mean ± SD of 3 
determinations.  **: p<0.01 statistically significant from the control group. 
** 
** 
** 
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Concentration-dependent inhibition of MDCK-2 monolayer resealing by TEIIAT 
Peptide 
The concentration-dependent activities of TEIIAT peptide were also evaluated in 
inhibiting the resealing of cell-to-cell adhesion at the intercellular junctions of MDCK-2 
cell monolayer. In this case, the intercellular junction was disrupted by incubating the 
monolayer with calcium-deficient medium for 1 h when the TEER value of the cell 
monolayer dropped. After 1 h, the medium was switch to calcium-sufficient medium 
(HBSS) to reseal the intercellular junction in the absence (control) and presence of 
TEIIAT peptide at different concentrations. The TEER values were measured every 
hour up to 6-h time point. The results showed that the TEER values of monolayers 
treated with HBSS were increased due to the resealing of the intercellular junctions 
(Figure 9). In contrast, the monolayers treated with peptides showed inhibition of TEER 
value increases from 2-h to 6-h time points due to inhibition of resealing of the 
intercellular junctions. The inhibition TEER value increase was dependent on the 
peptide concentration. At the 6-h time point, the effects of peptide concentrations were 
compared, and the peptide was found to significantly inhibit the resealing of the 
intercellular junction at concentrations of 189 µM or higher compared to HBSS control (p 
< 0.01).  
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Discussion 
The paracellular pathways of the intestinal mucosa and blood-brain barriers (BBB) 
can be exploited to increase the oral and brain delivery of drugs and diagnostic agents. 
In this case, the porosity of biological barriers in paracellular pathways can be increased 
via modulation of protein-protein interactions at the intercellular junctions. Several 
peptides derived from occludin and claudin at the tight junctions have been shown to 
modulate the intercellular junctions of the epithelial cell monolayers and improve the 
paracellular transport of marker (i.e., 14C-mannitol, 3H-inulin) and drug molecules [11, 
12]. Our group also designed HAV and ADT peptides from the EC-1 domain of E-
cadherin that can modulate in vitro and in vivo intercellular junctions to enhance delivery 
of marker and drug molecules in to the brain [9]. Thus, this work was to study whether 
peptides from other EC domains of E-cadherin could also modulate the intercellular 
junctions of biological barriers. In this case, the structural similarities of EC domains 
were evaluated by alignment analysis of EC domains. The alignments were computed 
using the Tree-base Best-first Iterative Algorithm with Tree-dependent partitioning 
(TBIAT) protein sequence multiple alignment analysis method [13].  As a result, 
decapeptides from EC-2, EC-3, and EC-4 that were aligned with the HAV and ADT 
peptides from the respective groove and bulge regions of EC-1 were synthesized (Table 
1).  The activities of these peptides in modulating E-cadherin-mediated cell-cell 
adhesion were evaluated using peptide inhibition of (a) Caco-2 single cell adhesion to 
Caco-2 cell monolayers and (b) resealing of the intercellular junctions of MDCK cell 
monolayers. 
The hypothesis is that the peptide inhibits cell adhesion by binding to E-cadherin and 
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blocks cadherin-cadherin interaction in the intercellular junctions to create greater 
paracellular porosity. E-cadherin is a Ca2+-dependent glycoprotein localized at adherens 
junctions and is responsible for cell-cell adhesion in the intercellular junctions of 
biological barriers.  E-cadherin homophilic interactions form cell-to-cell adhesion via 
stable trans-homophilic interactions of the domains [14]. The extracellular region of 
human E-cadherin is composed of 554 amino acid residues with five extracellular repeat 
domains (EC-1, -2, -3, -4, -5); EC-5 is also called the extracellular anchor (EA) domain 
[15]. The primary sequence homology values among the EC domains were low when 
calculated using the TBIAT program. The similarities among EC domains are between 
12.4 and 25.5%, with the highest similarity between EC-1 and EC-2 domains (25.5%). 
The similarities between the EC-5 and other EC domains were low (between 5.8 and 
8.4%). 
It has been shown that the EC-1 domain was important for E-cadherin-mediated cell 
adhesion [16]. HAV and ADT peptides derived from the respective groove and bulge 
regions of EC-1 domain inhibited E-cadherin-mediated cell-cell adhesion to modulate 
the intercellular junctions of in vitro and in vivo biological barriers [8]. Thus, the 
hypothesis is that the peptides derived from the groove and bulge regions of other EC 
domains (i.e., EC-2, EC-3, EC-4) can inhibit E-cadherin-mediated cell adhesion. Here, 
the activities of peptides derived from other EC domains were compared in inhibiting 
adhesion of Caco-2 single cells to Caco-2 cell monolayers. Adhesion of Caco-2 single 
cells to Caco-2 cell monolayers was mediated between E-cadherins on the single cells 
and E-cadherins found on the surface of the cell monolayers (Figure 1C). In the 
permeabilized Caco-2 cell monolayers using Triton X-100, E-cadherin molecules were 
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recognized by anti-E-cadherin mAb at the individual cell fringes, suggesting that most E-
cadherins were located in the intercellular junctions (Figure 1B). On the other hand, 
some distributed E-cadherin molecules were detected on the surface of the non-
permeabilized Caco-2 cell monolayers in an immunofluorescence staining study (Figure 
1A). Anti-E-cadherin mAb inhibited Caco-2 single cell adhesion to Caco-2 cell 
monolayers, suggesting that the cell adhesion was mediated by E-cadherin. As another 
positive control, peptide 9 with HAV sequence suppressed single cell adhesion in a 
concentration-dependent manner (Figure 5); this peptide was previously found to 
effectively block E-cadherin-mediated aggregation of bovine brain endothelial 
microvessel cells (BBMECs) [17]. 
In this assay, peptide 6 and peptide 8 from the respective EC-2 and EC-4 domains 
were significantly active in inhibiting cell adhesion compared to control (HBSS). As a 
negative control, peptide 0 with scrambled sequences did not show any activity. As a 
positive control, peptide 9 significantly inhibited cell adhesion at 500 μM (Figure 3). 
Peptide 6 inhibited cell adhesion in concentration-dependent inhibition manner with 
significant inhibition at 1000 μM (Figure 5). Interestingly, peptide 8 inhibited cell 
adhesion as low as 250 μM, which suggested that this peptide had better activity than 
peptide 6. Because peptide 8 had high activity, further studies were done to reduce the 
size of the peptide from decapeptides to hexapeptides to find the small active region of 
this peptide.   
The size of cadherin peptides can influence their penetration into the intercellular 
junctions of the BBB [8, 18]. It has been shown that HAV hexapeptides can penetrate 
the intercellular junctions of BBB in vivo to modulate biological barriers for enhancing 
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brain delivery of marker molecules [10]. Thus, peptide 8 was reduced to overlapping 
hexapeptides 10–14 (Table 2), and the results showed that peptide 12 (ALIIAT) had the 
most consistent activity at 500, 750, and 1000 μM (Figure 6). As expected, peptide 12 
had lower activity than the parent peptide 8. A similar trend was previously observed 
when peptide 9 (HAV peptide) was reduced to deca- and hexapeptides [9]. Lower 
activities of small peptides were due to the loss of secondary structure and flanking 
residues from the basic active sequence such as the His-Ala-Val sequence in HAV 
peptide [19]. Because peptide 12 was the best hexapeptide derivative, it was subjected 
to alanine scanning and mutation studies to find a better peptide. 
To find residues that are important for peptide activity, an alanine-scanning study 
was performed on peptide 12 (ALIIAT) to make peptides 15–18. The ability to inhibit 
single cell adhesion was evaluated at 250 μM (Figure 7). This study showed that 
replacing residues 2, 4, and 6 with alanine enhanced the activity of the peptides, 
suggesting that reducing the bulkiness of the side chain of these residues improved 
peptide activities. To test the importance of Ala-1 residue in ALIIAT (peptide 12), it was 
replaced with Thr-1 to make peptide 19 (TLIIAT); this replacement did not improve the 
activity compared to that of parent peptide 12 (ALIIAT). Then, residue 2 in peptide 19 
was also replaced with aromatic residue Ala-2 (small hydrophobic), Phe-2 (hydrophobic 
aromatic), Glu-2 (acidic residue), Asn-2 (neutral residue), and Arg-2 (basic residue). As 
in peptide 15 (AAIIAT), mutation on the Ala-2 residue on peptide 19 to peptide 20 
(TAIIAT) enhanced peptide activity. Peptide 22 (TEIIAT) and peptide 23 (TNIIAT) had 
high inhibitory activity of single cell adhesion, suggesting that the acidic (Glu-2) and 
neutral hydrophilic (Asn-2) residues were better amino acids for position 2 compared to 
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hydrophobic and basic residues. In the future, similar mutations (i.e., Ala, Phe, Glu, Asn, 
Arg) at positions 4 and 6 will be carried out on peptide 22 to improve its activity.  
The activity of peptide 23 (TEIIAT) was confirmed with another biological assay 
called a resealing assay using MDCK II cell monolayers. The idea was that the junctions 
of monolayers were disrupted by removing calcium ions from the medium followed by 
resealing the junctions by adding calcium to the medium. During the resealing process, 
TEIIAT peptide was added at different concentrations. The peptide was very effective in 
inhibiting the resealing of the intercellular junctions of MDCK II cell monolayers, with 
50% inhibition of resealing seen at a concentration of 189 μM. Compared to previous 
deca- and hexapeptides derived from HAV- and ADT-peptides, peptide 23 (TEIIAT) may 
have better inhibitory activity in inhibiting E-cadherin-mediated cell adhesion. Further 
studies need to be done to provide side-by-side comparisons of the activities of peptide 
23 and other HAV- and ADT-peptides 
 
Conclusions 
This study found that peptides 6 and 8 from the groove region of the respective EC-2 
and EC-4 domains of E-cadherin inhibit Caco-2 single cell adhesion to Caco-2 cell 
monolayers. Peptide 8 had better inhibitory ability than peptide 6. Reduction of peptide 
8 to hexapeptides produced peptide 12 (ALIIAT) with better activity than other 
hexapeptides derived from peptide 8. Alanine-scanning and mutation studies of peptide 
12 produced a very active peptide 22 (TEIIAT), which effectively inhibited Caco-2 single 
cell adhesion to cell monolayers and intercellular junctions of MDCK II cell monolayers. 
In the future, peptide 22 will be evaluated for enhancing the delivery of MRI contrast 
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agents (i.e., Gd-DTPA), Gd-DTPA-labeled peptides, and NIR-dye-labeled peptides. 
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